NDC 62756-091
Medroxyprogesterone Acetate 150 mg per 1 mL injection, suspension
On the label: Caraco Pharmaceutical Laboratories, Ltd..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Halol, India | Makes it and tests it | Serious problems, FDA actionJun 13, 2025 · 12 inspections, 5 with FDA action |
Recalls
- May 6, 2022 · Class II · Sun Pharmaceutical Industries Inc
Lack of assurance of sterility
Lots: Lot #: HAC1951A, Exp 06/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Medroxyprogesterone: every company that makes it
- Form
- injection, suspension, intramuscular
- Strength
- 150 mg per 1 mL
- Approval
- ANDA ANDA210761
- On the market since
- May 1, 2019
- Package NDCs
62756-091-40- Official label
- DailyMed (National Library of Medicine), updated Dec 14, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?